Blonder Tongue Laboratories, Inc.
BDRL
$0.21
$0.000.00%
| Weiss Ratings | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.08 | |||
| Price History | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.60% | |||
| 30-Day Total Return | -29.53% | |||
| 60-Day Total Return | 31.25% | |||
| 90-Day Total Return | 16.47% | |||
| Year to Date Total Return | 23.53% | |||
| 1-Year Total Return | -70.09% | |||
| 2-Year Total Return | -85.62% | |||
| 3-Year Total Return | -65.59% | |||
| 5-Year Total Return | -73.42% | |||
| 52-Week High % Change | -72.73% | |||
| 52-Week Low % Change | 110.00% | |||
| Price | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.77 | |||
| 52-Week Low Price | $0.10 | |||
| 52-Week Low Price (Date) | Jun 27, 2022 | |||
| 52-Week High Price (Date) | Apr 21, 2022 | |||
| Valuation | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $3.21M | |||
| Enterprise Value | 13.86M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.32 | |||
| Earnings Per Share Growth | 74.25% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.19 | |||
| Price/Book (Q) | 3.40 | |||
| Enterprise Value/Revenue (TTM) | 0.80 | |||
| Price | $0.21 | |||
| Enterprise Value/EBITDA (TTM) | -4.41 | |||
| Enterprise Value/EBIT | -4.16 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 13.333M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 732 679 4000 | |||
| Address | One Jake Brown Road Old Bridge, NJ 08857 | |||
| Website | www.blondertongue.com | |||
| Country | United States | |||
| Year Founded | 1950 | |||
| Profitability | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -19.22% | |||
| Profit Margin | -23.39% | |||
| Management Effectiveness | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -14.75% | |||
| Return on Equity | -- | |||
| Income Statement | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $16.83M | |||
| Total Revenue (TTM) | $16.83M | |||
| Revenue Per Share | $1.26 | |||
| Gross Profit (TTM) | $4.78M | |||
| EBITDA (TTM) | -$3.05M | |||
| EBIT (TTM) | -$3.24M | |||
| Net Income (TTM) | -$3.94M | |||
| Net Income Avl. to Common (TTM) | -$3.94M | |||
| Total Revenue Growth (Q YOY) | 26.13% | |||
| Earnings Growth (Q YOY) | -249.75% | |||
| EPS Diluted (TTM) | -$0.32 | |||
| EPS Diluted Growth (Q YOY) | -163.50% | |||
| Balance Sheet | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $167.00K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | $8.23M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $937.00K | |||
| Current Ratio (Q) | 0.973 | |||
| Book Value Per Share (Q) | $0.07 | |||
| Total Assets (Q) | $15.28M | |||
| Total Current Liabilities (Q) | $8.46M | |||
| Total Debt (Q) | $10.82M | |||
| Total Liabilities (Q) | $14.34M | |||
| Total Common Equity (Q) | $937.00K | |||
| Cash Flow | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$61.00K | |||
| Cash from Financing (TTM) | $2.09M | |||
| Net Change in Cash (TTM) | -$104.00K | |||
| Levered Free Cash Flow (TTM) | -$1.05M | |||
| Cash from Operations (TTM) | -$2.13M | |||
